$BSBR

Santander Brasil (BSBR) Q2 2026 Earnings Call Transcript

Santander Brasil (BSBR) held its Q2 2026 earnings call. Management reported recurring net income of BRL 3 billion and ROAE of 12.5%, citing a tougher macro environment and higher cost of risk. It said it cut exposure to low-income clients by 30%, grew loans in cards, consumer finance and SMEs, and expanded Santander Rewards and PIX usage while maintaining a 50% payout benchmark.

Original reporting
Published Jul 30, 2026, 8:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Santander Brasil (BSBR) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$BSBRNeutralMed
01

Why it matters

Management emphasized recurring net income of BRL 3 billion and ROAE of 12.5% despite a challenging macro and higher cost of risk, while reducing low-income exposure and tightening loan renegotiations. It also guided that tax credit turnaround is expected in 2027-2028 and suggested NII recovery may be closer to 2027.

02

Market read

Traders can update expectations for BSBR’s earnings durability, credit-cost trajectory, and the timing of NII normalization and tax-credit benefits based on management’s stated targets and constraints.

03

What to watch

The transcript highlights one-off provisioning (BRL 700m) and a nonperforming loan classification adjustment (29 bps); traders may need to separate underlying credit trends from accounting/methodology effects.

Relevance 8/10Novelty 7/10Timing: ahead of/for positioning around the Q2 2026 earnings read-through and 2027-2028 tax credit timing

Background

This is a Q2 2026 earnings call transcript for Banco Santander (Brasil) S.A., focused on recurring profitability, customer/product mix, credit costs, and capital return policy.

Company-level read

Ticker impact

$BSBRNeutralMedium confidence
Context

Santander Brasil reported recurring net income of BRL 3 billion and ROAE of 12.5%, citing higher cost of risk and a balance-sheet mix shift.

Expected impact

Near-term sentiment likely mixed: supportive for ROAE durability via mix shift, but negative for risk-cost pressure and slower NII recovery timing.

Evidence & confidence

The article provides multiple decision-relevant datapoints (recurring net income, ROAE, provisioning, payout policy, renegotiation collateral requirements, and NII recovery timing around 2027) that can change trader expectations for earnings power and credit costs.

Market effects

Brazil bank peers may face read-across on credit-cost sensitivity, provisioning behavior, and how quickly NII can normalize after risk reclassification.

Could influence broader Brazil financials sentiment if investors treat the 2027 NII recovery and restrictive renegotiations as a sector signal.

Limited direct global spillover, but it can affect EM bank credit-risk and funding-cost narratives for investors with Brazil exposure.

Counterpoint

The mix shift toward higher-income and secured SME collateral could prove more resilient than management implies, making the 2027 NII recovery timeline conservative.

Key entities

  • Banco Santander (Brasil) S.A.

    Subject of the earnings call transcript, reporting Q2 2026 recurring net income, ROAE, and balance-sheet/customer rebalancing actions.

  • Carlos Muniz

    CFO who discussed cost of risk, provisioning, loan renegotiation stance, and timing for NII recovery and tax credit turnaround.

  • Camila Toledo

    Investor Relations host for the earnings call.

Related articles

$BSBRMed

Santander Brasil (BSBR) Q2 2026 Earnings Call Transcript

Banco Santander (Brasil) S.A. (BSBR) held its Q2 2026 earnings call. Management reported recurring net income of BRL 3 billion and ROAE of 12.5%. It said it reduced exposure to low-income clients by 30%, grew loans in cards, customer finance and SMEs, and increased transactional deposits 18%. The efficiency ratio was 39.3%, with BRL 700 million in one-off provisioning items.

$SANMed

Santander Q2 Profit Rises; Confirms FY26 Outlook, 3-yr Plan

Banco Santander reported Q2 2026 profit attributable to the parent up 3% to €3.52 billion, and underlying profit attributable up 17% to €3.77 billion. Underlying profit before tax rose 14% to €5.32 billion. For FY26, Santander confirmed targets including mid-single-digit revenue growth, lower constant-euro costs, and CET1 of 12.8% to 13%.

$SCCOMedAI 8/10

Chile’s Stock Market Dips 0.7% but Keeps Its Big Gain

Chile’s S&P IPSA fell 0.73% to 10,747.02 on Tuesday (May 26), after a 2.48% copper-amplified gain on Monday, according to the Bolsa de Comercio de Santiago. The index opened near Monday’s close and traded in a narrow range. The Banco Central of Chile’s policy rate is 4.50%, with a June cut toward 4.25% in view.

$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.

$BRK-BMed

Berkshire Hathaway Just Did Something It Hasn’t Done in More Than 3 Years

Berkshire Hathaway reported Q2 2026 cash and Treasury bills of $365.5 billion, down from $397.4 billion in Q1, ending a 14-quarter streak as a net seller. According to Berkshire, CEO Greg Abel became a net buyer of equities, adding about $20 billion net, and increased buybacks to $4.5 billion. Apple fell to 20% of the portfolio; Alphabet rose after a $10 billion investment.